Prolonged oral acyclovir administration associated with neutropenia and thrombocytopenia.
Grella
M
M
Children's National Medical Center, Washington, DC 20010, USA.
Ofosu
J R
JR
Klein
B L
BL
D000212:Acyclovir / Q000009:adverse effects*; D000284:Administration, Oral; D000998:Antiviral Agents / Q000009:adverse effects*; D002648:Child; D002908:Chronic Disease; D006560:Herpes Labialis / Q000188:drug therapy; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000139:chemically induced*; D009504:Neutrophils; D018579:Patient Selection; D010976:Platelet Count; D017410:Practice Guidelines as Topic; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced*; D013997:Time Factors
D000998:Antiviral Agents; D000212:Acyclovir